Dr. Thomas McCauley (UAB Physics PhD - Class of 1996) has assumed a Vice President position at Shire Pharmaceuticals. Dr. McCauley joined Shire in 2010 and heads its global nonclinical development.
In addition to his current focus on research and development of novel therapeutics for the Rare Disease, Neuroscience, Gastrointestinal, Internal Medicine and Regenerative Medicine business units, Tom has over thirteen years of experience in the biotechnology and pharmaceutical industries in preclinical and clinical discovery and development of biologic and small molecule drugs for indications in cardiovascular disease, hematology, oncology, inflammation and ophthalmology.
He holds undergraduate and graduate degrees from Cornell University, and received his PhD from the University of Alabama at Birmingham. Dr. McCauley's thesis work was in chemical vapor deposited diamond research. Previously Dr. McCauley worked at Brandies University and Argonne National Laboratory.
Physics Alumnus Thomas McCauley Heads Nonclinical Development Group at Shire Pharmaceuticals
Trailblazing Alumni
CAS News
April 19, 2015
More News
-
Is AI competent to make moral judgments? A UAB philosopher helped devise tests to find out.Recent studies have some researchers touting AI’s ethical reasoning prowess. In a Nature paper, UAB’s Joshua May, Ph.D., joined scientists from Google DeepMind to explain how to get proof. -
UAB lands 17 graduate programs in top 20 rankingsUAB earns multiple top rankings in the 2026 U.S. News Best Graduate Schools, highlighting national excellence across health, nursing, business and engineering programs. -
CAS invests in student success with Books for Blazers initiativeFinancial concerns can be the difference between a smooth or challenging college experience. Many can secure scholarships to offset the expenses of tuition, but as every graduate knows, other costs can become barriers to success.